PDSinh-C01
PDSinh-C01 is a reversible, non-competitive pendrin (SLC26A4) inhibitor with an IC50 of 2.5 μM. PDSinh-C01 inhibits pendrin-mediated Cl−/SCN− exchange activity, reduces cell counts, protein levels, and pro-inflammatory cytokine production in bronchoalveolar lavage fluid. PDSinh-C01 can be used in research related to acute lung injury and cystic fibrosis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2128304-65-2
- Formule: C20H23N3O2S2
- Masse moléculaire:401.55
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
PDSinh-C01 (1-100 μM; 10 min) inhibits pendrin-mediated Cl−/SCN− exchange activity in CHO-K1 cells expressing human pendrin, with an IC50 of 5.29 μM[1].
PDSinh-C01 (0.1-30 μM; 24 h) reduces the cell viability of HPAEpiC[1].
PDSinh-C01 (20 μM; 25 h) significantly reduces the expression levels of pendrin and phosphorylated IκB in LPS (HY-D1056)-induced HPAEpiC[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:LPS-stimulated HPAEpiC
-
Concentration:20 μM
-
Incubation Time:1 h (pre-incubation prior to 24 h LPS stimulation)
-
Result:Significantly reduced LPS-increased pendrin/β-actin and phospho-IκB/total IκB ratios to levels comparable to vehicle control.
In Vivo
PDSinh-C01 (10 mg/kg; i.p.; administered twice) alleviates LPS-induced acute lung injury in male C57BL/6J mice and reduces key inflammatory and injury markers[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J (male, 8 weeks old, 20-25 g, intranasal instillation of 10 mg/kg LPS)[1]
-
Dosage:10 mg/kg
-
Administration:i.p.; single dose 1 hour prior to LPS exposure
-
Result:Significantly reduced LPS-induced increases in BALF total cell counts, protein concentration, and neutrophil counts compared to the LPS-only group.
Significantly reduced lung injury scores, pendrin protein expression, phospho-IκB protein expression, pendrin mRNA levels, and lung tissue levels of pro-inflammatory cytokines IL-1β, MIP-2, IL-6, and TNF-α compared to the LPS-only group.
Showed significantly higher lung injury scores than in the YS-01-treated pre-treatment group.
-
Animal Model:C57BL/6J (male, 8 weeks old, 20-25 g, intranasal instillation of 10 mg/kg LPS)[1]
-
Dosage:10 mg/kg
-
Administration:i.p.; two doses at 6 and 12 hours after LPS exposure
-
Result:Significantly reduced LPS-induced increases in BALF total cell counts, protein concentration, neutrophil counts, and macrophage counts compared to the LPS-only group.
Significantly reduced lung injury scores (with scores significantly lower than in the YS-01-treated post-treatment group), pendrin protein expression, phospho-IκB protein expression, pendrin mRNA levels, and lung tissue levels of pro-inflammatory cytokines IL-1β, MIP-2, IL-6, and TNF-α compared to the LPS-only group.
Chemical Information
-
CAS No. 2128304-65-2
-
Masse moléculaire 401.55
-
Formule C20H23N3O2S2
-
SMILES
CC1=NNC(C2=CC(S(NC3C(C=CC=C4)=C4CCC3)(=O)=O)=C(C)S2)=C1C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Fibrosis/Collagen Morphometry
Fibrosis and collagen morphometry is based on the quantitative visualization of fibrillar collagen deposition in tissue sections using histochemical stains such as Sirius Red (Picrosirius Red) or Masson's trichrome, followed by image-based or polarization-enhanced analysis to estimate collagen proportional area as a surrogate of extracellular matrix accumulation during fibrotic remodeling. Sirius Red combined with polarized light microscopy enhances detection of collagen fibers due to birefringence properties, enabling more specific visualization of collagen type I and III fibrils compared to conventional bright-field histology, while whole-section or region-restricted digital morphometry reduces field-selection bias in fibrosis assessment. Alternative quantitative approaches include second harmonic generation (SHG) and two-photon excited fluorescence microscopy, which enable label-free detection of fibrillar collagen and have been validated against histological staining and biochemica
-
Collagen: Sirius Red Staining
Sirius Red or picrosirius red staining is a histochemical method for visualizing collagen-rich extracellular matrix in tissue sections, and collagen fibers are detected as red-stained structures under bright-field microscopy with enhanced birefringence under polarized light. Picrosirius red is useful for assessing total collagen organization, distribution, and fibrosis burden, but polarized color should not be interpreted as a definitive collagen type I versus type III readout because color is affected by fiber orientation, thickness, and packing.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Connective Tissue: Masson's Trichrome/Collagen Trichrome Staining
Masson’s Trichrome (collagen/trichrome staining) is a histological technique that differentially stains tissue compartments using sequential acidic dyes to distinguish collagen from muscle and cytoplasmic components based on dye affinity and tissue permeability differences, enabling visualization of fibrosis and connective tissue architecture in histological sections. The classical formulation typically uses Weigert's iron hematoxylin for nuclear staining, Biebrich scarlet-acid fuchsin for cytoplasm and muscle, and aniline blue (or light green variants) for collagen, producing a characteristic blue/green collagen signal contrasted against red cytoplasm and dark nuclei. The staining principle relies on selective displacement of smaller dye molecules by larger anionic dyes in collagen-rich regions under controlled acidified conditions, which enhances collagen-specific dye retention. This property makes the method widely used for fibrosis assessment in organs such as heart, liver, lung, a
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Inhalation Toxicity Study
Inhalation toxicity studies expose rodents to a controlled aerosol, vapor, gas, or smoke atmosphere and assess respiratory and systemic toxicity using exposure-atmosphere characterization, clinical observations, body and organ weights, bronchoalveolar lavage fluid, histopathology, blood chemistry, hematology, and, when included, molecular endpoints such as transcriptomics, proteomics, lipidomics, or tissue burden analysis. The primary biological readouts are airway irritation, pulmonary inflammation, cytotoxicity, altered surfactant or lipid homeostasis, impaired particle clearance, and tissue remodeling, reflected by BALF cell differentials, BALF protein, LDH, phosphatase activities, cytokines, lung weight, microscopic respiratory-tract lesions, and retained lung burden.
Pureté et documentation
Références
[1]. Choi HK, et al. The comparison of two pendrin inhibitors, YS-01 and PDSinh-C01, in lipopolysaccharide-induced acute lung injury. Scientific reports. 2026 Jun 23. [Content Brief]
[2]. Lipani A, et al. Modulators of anion channels and transporters as alternative therapeutic agents to normalize airway surface liquid in cystic fibrosis. European journal of medicinal chemistry. 2026 Jan 15;302(Pt 2):118325. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)